PapersFlow Research Brief
Urinary Bladder and Prostate Research
Research Guide
What is Urinary Bladder and Prostate Research?
Urinary Bladder and Prostate Research is a field in urology that standardizes terminology, diagnosis, and treatment for lower urinary tract function, focusing on conditions including lower urinary tract symptoms, benign prostatic hyperplasia, overactive bladder, urinary incontinence, urodynamic practices, neurogenic lower urinary tract dysfunction, detrusor overactivity, bladder outlet obstruction, interstitial cystitis, and prostate inflammation.
The field encompasses 95,394 works on standardization of terminology, diagnosis, and treatment of lower urinary tract conditions. Key areas include benign prostatic hyperplasia, overactive bladder, and urinary incontinence. Growth rate over the past 5 years is not available.
Topic Hierarchy
Research Sub-Topics
Benign Prostatic Hyperplasia
Research focuses on pathophysiology, medical therapies like alpha-blockers, and surgical interventions such as TURP. Studies explore biomarkers, progression models, and quality-of-life impacts.
Overactive Bladder Syndrome
This sub-topic investigates antimuscarinic drugs, beta-3 agonists, and neuromodulation for urgency incontinence. Clinical trials assess symptom severity indices and patient adherence.
Lower Urinary Tract Symptoms
Studies standardize LUTS classification using IPSS, etiology differentiation, and multimodal therapies. Emphasis includes gender differences and comorbidity effects.
Urodynamic Practices
Researchers validate pressure-flow studies, uroflowmetry, and videourodynamics for dysfunction diagnosis. Debates center on clinical utility and standardization protocols.
Urinary Incontinence
This area covers stress, urge, and mixed incontinence epidemiology, pelvic floor therapies, and slings. Population studies like EPIC inform prevalence and risk factors.
Why It Matters
This research enables standardized diagnosis and treatment of conditions affecting millions, such as benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Abrams et al. (2002) in "The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society" established consistent terms used globally for LUTS assessment. Barry et al. (1992) developed the American Urological Association Symptom Index, validated in 210 BPH patients and 108 controls, which quantifies symptoms to guide therapy. Dong et al. (2013) meta-analysis of randomized trials showed tadalafil improves LUTS/BPH safely. The EPIC study by Irwin et al. (2006) surveyed five countries, revealing prevalence data that informs public health strategies for urinary incontinence and overactive bladder.
Reading Guide
Where to Start
"The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society" by Abrams et al. (2002), as it provides foundational terms essential for understanding all subsequent research on LUTS, BPH, and related conditions.
Key Papers Explained
Abrams et al. (2002) in "The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society" (8198 citations) sets baseline terminology, which Abrams et al. (2003) in "The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society" (3120 citations) reinforces in Urology. Barry et al. (1992) in "The American Urological Association Symptom Index for Benign Prostatic Hyperplasia" (3373 citations) builds on this by validating a symptom index for BPH. Dong et al. (2013) in "Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis" (4539 citations) applies these standards to evaluate treatments. Berry et al. (1984) in "The Development of Human Benign Prostatic Hyperplasia with Age" (2472 citations) provides etiological context on age-related prostate growth.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues on standardizing terminology for complex conditions like neurogenic lower urinary tract dysfunction and interstitial cystitis, building on ICS reports. No recent preprints or news available indicate focus remains on applying established guidelines from top-cited works like Abrams et al. (2002) and Haylen et al. (2009).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The standardisation of terminology of lower urinary tract func... | 2002 | Neurourology and Urody... | 8.2K | ✕ |
| 2 | Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary... | 2013 | Urologia Internationalis | 4.5K | ✓ |
| 3 | Campbell's urology | 1986 | — | 3.5K | ✕ |
| 4 | The American Urological Association Symptom Index for Benign P... | 1992 | The Journal of Urology | 3.4K | ✕ |
| 5 | The standardisation of terminology in lower urinary tract func... | 2003 | Urology | 3.1K | ✕ |
| 6 | An international urogynecological association (IUGA)/internati... | 2009 | Neurourology and Urody... | 3.0K | ✓ |
| 7 | Development and evaluation of an abridged, 5-item version of t... | 1999 | International Journal ... | 2.9K | ✕ |
| 8 | International Clinical Practice Guidelines for the Treatment o... | 2011 | Clinical Infectious Di... | 2.9K | ✕ |
| 9 | Population-Based Survey of Urinary Incontinence, Overactive Bl... | 2006 | European Urology | 2.6K | ✕ |
| 10 | The Development of Human Benign Prostatic Hyperplasia with Age | 1984 | The Journal of Urology | 2.5K | ✕ |
Frequently Asked Questions
What is the standard terminology for lower urinary tract function?
Abrams et al. (2002) in "The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society" provide the report from the International Continence Society's sub-committee. This standardizes terms for storage and voiding symptoms. It is widely adopted in clinical practice and research.
How is the severity of benign prostatic hyperplasia symptoms measured?
Barry et al. (1992) in "The American Urological Association Symptom Index for Benign Prostatic Hyperplasia" developed and validated a symptom index. It was tested on 210 BPH patients and 108 controls. The index scores urinary symptoms to assess disease impact.
What is the efficacy of tadalafil for LUTS due to BPH?
Dong et al. (2013) in "Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis" evaluated randomized controlled trials. Tadalafil monotherapy showed efficacy and safety for LUTS/BPH. It improves symptoms without major adverse effects.
What are the prevalence rates of urinary incontinence and overactive bladder?
Irwin et al. (2006) in "Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study" conducted a population-based survey. It reported prevalence across five countries for these conditions. Results guide epidemiological understanding.
How does benign prostatic hyperplasia develop with age?
Berry et al. (1984) in "The Development of Human Benign Prostatic Hyperplasia with Age" analyzed data from over 1,000 prostates across 10 studies. Normal prostate weight is 20 ± 6 g in men aged 21-30. BPH prevalence and growth increase with age.
What terminology applies to female pelvic floor dysfunction?
Haylen et al. (2009) in "An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction" updated terms for pelvic floor issues in women. It uses a female-specific, clinically based consensus. This complements lower urinary tract terminology.
Open Research Questions
- ? How can urodynamic practices be refined to better distinguish detrusor overactivity from other causes of urinary incontinence?
- ? What are the long-term outcomes of tadalafil monotherapy compared to combination therapies for LUTS/BPH?
- ? How does neurogenic lower urinary tract dysfunction vary across different neurological conditions?
- ? What factors drive the age-related growth rate of prostate enlargement in BPH beyond the baseline 20 g weight?
- ? How can terminology standards be updated to incorporate emerging data on interstitial cystitis and bladder outlet obstruction?
Recent Trends
The field maintains 95,394 works with no specified 5-year growth rate.
Highly cited standards from Abrams et al. (2002, 8198 citations) and Dong et al. (2013, 4539 citations) continue to dominate, reflecting sustained reliance on foundational terminology and BPH treatments.
No recent preprints or news coverage available.
Research Urinary Bladder and Prostate Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Urinary Bladder and Prostate Research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers